Keyphrases
Positron Emission Tomography
100%
Clinical Utility
100%
Malignant Melanoma
100%
Stage III Disease
100%
Melanoma
23%
Fluorodeoxyglucose
23%
Positive Area
23%
Patient Demographics
15%
Predictive Value
15%
Cancer Patients
7%
Etiology
7%
Whole-body
7%
Computed Tomography
7%
Malignancy
7%
Arthritis
7%
Clinical Management
7%
Clinical Information
7%
Lymph Node
7%
Metabolic Activity
7%
Patient Management
7%
Metastatic Disease
7%
Non-associated
7%
Pathological Examination
7%
After Injection
7%
False Positive Rate
7%
Prospective Evaluation
7%
Increased Activity
7%
Positive Check
7%
Colonic Polyps
7%
Same Patient
7%
In-transit Melanoma
7%
Further Surgery
7%
Fluorine-18
7%
Microscopic Disease
7%
American Joint Committee on Cancer
7%
Abnormal Area
7%
Stage III Melanoma
7%
Skin Nevi
7%
Prophylactic Lymph Node Dissection
7%
Phlebitis
7%
Medicine and Dentistry
Disease
100%
Positron Emission Tomography
100%
Melanoma
100%
False Positive Result
30%
Glucose
23%
Patient Population
15%
Infection
7%
Cancer
7%
Metastatic Carcinoma
7%
Clinical Management
7%
Lymph Node
7%
Retroperitoneal Lymph Node Dissection
7%
Arthritis
7%
Computer Assisted Tomography
7%
Fluorine-18
7%
Colon Polyp
7%
Phlebitis
7%
Whole Body PET
7%
Polyethylene Terephthalate
7%
Nevus
7%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Melanoma
100%
Glucose
42%
Malignant Neoplasm
14%
Infection
14%
Metastasis
14%
Arthritis
14%
Fluorine 18
14%
Phlebitis
14%
Nevus
14%
Colon Polyp
14%
Polyethylene Terephthalate
14%